Milestone Pharmaceuticals

Jul 16, 2019

Pappas Capital Expands Leadership Team With Appointments Of Kyle Rasbach To Managing Partner And Matthew Boyer To Chief Financial Officer

Apr 16, 2019

Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

Aug 08, 2018

Milestone Pharmaceuticals Announces First Patient Randomized in the Phase 3 NODE-301 Clinical Trial Evaluating Etripamil for Termination of Paroxysmal Supraventricular Tachycardia (PSVT) Episodes

Jun 18, 2018

Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder

Mar 12, 2018

Milestone Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference

Nov 14, 2017

Patient Registry Shines Spotlight on PSVT, an Overlooked Heart Disorder

Oct 24, 2017

Milestone Pharmaceuticals Appoints Lorenz Muller as Chief Commercial Officer

Aug 01, 2017

Milestone Pharmaceuticals Closes $55 Million Series C Financing